Trial Site Detail

 

Drug:
Nilotinib or Imatinib
Trial:
Phase III, Open-Label Study of Nilotinib Versus Imatinib in GIST Patients (ENESTg1)
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Completed

 

St. Luke's Hospital & Health Network

     
Bethlehem , PA 18015
USA

 

Principal Investigator:
Sanjiv Agarwala, MD
Contact:
Susan Reed 610-954-6013 reedsu@slhn.org
Activation Status of this Site:
Closed
Notes about this Site:
St. Luke's Hospital & Health Network Website:

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.